In today’s briefing:
- Bionote IPO Trading – Weakest Demand Even After Cutting Price and Size
Bionote IPO Trading – Weakest Demand Even After Cutting Price and Size
- Bionote (377740 KS) raised US$72.2m in its Korean IPO. The IPO had consisted of both a primary and secondary selldown.
- Bionote is an integrated producer of diagnostics test products and biocontent products.
- In this note, we will talk about the demand for the deal and other trading dynamics.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
